0001519749-21-000011.txt : 20210921 0001519749-21-000011.hdr.sgml : 20210921 20210921181842 ACCESSION NUMBER: 0001519749-21-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210917 FILED AS OF DATE: 20210921 DATE AS OF CHANGE: 20210921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hart Jayne B. CENTRAL INDEX KEY: 0001519749 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 211267460 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 BUSINESS PHONE: 801-584-3600 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-09-17 0 0000899923 MYRIAD GENETICS INC MYGN 0001519749 Hart Jayne B. 320 WAKARA WAY SALT LAKE CITY UT 84108 0 1 0 0 Chief People Officer Common Stock 2021-09-17 4 M 0 73225 26.49 A 153287 D Common Stock 2021-09-17 4 S 0 64480 33.72 D 88807 D Common Stock 2021-09-17 4 M 0 3775 26.49 A 92582 D Common Stock 2021-09-17 4 S 0 2966 33.72 D 89616 D Incentive Stock Option (right to buy) 26.49 2021-09-17 4 M 0 3775 0.0 D 2021-09-17 Common Stock 3775 0 D Non-Qualified Stock Option (right to buy) 26.49 2021-09-17 4 M 0 73225 0.0 D 2021-09-17 Common Stock 73225 0 D Represents the net exercise of outstanding stock options. The reporting person received 8,745 shares of common stock on net exercise of options to purchase 73,225 shares of common stock. The company withheld 64,480 shares of common stock for payment of the exercise price and tax withholdings, using the closing stock price on September 17, 2021 of $33.72. Represents the net exercise of outstanding stock options. The reporting person received 809 shares of common stock on net exercise of options to purchase 3,775 shares of common stock. The company withheld 2,966 shares of common stock for payment of the exercise price and tax withholdings, using the closing stock price on September 17, 2021 of $33.72. The shares subject to this option are fully vested and exercisable. By: Nathan A. Smith For: Jayne B. Hart 2021-09-21